Albumin fusion of the rVWF fragment rD'D3 reduces internalisation by clearance receptor Stabilin-2
Blood Cells, Molecules, and Diseases · 2026-07 · 119 · 103000
DOI: 10.1016/j.bcmd.2026.103000 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Cells, Molecules, and Diseases, 2026-07. Verfasst von Kim G Lieu und 10 weiteren Autor:innen. Beteiligte Einrichtung: CSL Innovation Pty Ltd, Parkville, Victoria, Australia. Electronic address: kim.lieu@csl.com.au. Hauptthemen laut MEDLINE: Recombinant Fusion Proteins, von Willebrand Factor, Cell Adhesion Molecules, Neuronal, Albumins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
A recombinant VWF D'D3 albumin fusion protein (rD'D3-FP) has been developed to extend the half-life of co-administered coagulation factor VIII (FVIII) for the treatment of haemophilia A. We examined the impact of albumin fusion of rD'D3 on the Stabilin-2 (STAB2) clearance receptor pathway and rD'D3-FP recycling via engagement of the neonatal Fc receptor FcRn as two potential mechanisms for rD'D3-FP half-life extension. Binding and intracellular trafficking of fluorescently labelled rD'D3-FP was examined using human 293-F cells overexpressing STAB2 or in combination with FcRn by flow cytometry and confocal microscopy. Pharmacokinetics of rD'D3-FP in FVIII knock out (KO), FcRn KO and hFcRn Tg32 transgenic mice was also assessed. We show that the interaction of rD'D3-FP and his-tagged rD'D3 with STAB2 is optimal at neutral pH but dissociates under acidic conditions. Whilst albumin fusion appears to hinder interaction of rD'D3-FP with STAB2, STAB2-mediated internalisation and lysosomal degradation of rD'D3-FP could be observed in an in vitro system. Rescue of rD'D3-FP via diversion into Rab11+ recycling endosomes was achieved with the co-expression of STAB2 and FcRn. A significant improvement in rD'D3-FP pharmacokinetics was observed compared to his-tagged rD'D3, however, only a modest improvement in rD'D3-FP half-life extension was observed in hFcRn Tg32 mice compared to FcRn KO and wild-type mice. Whilst FcRn may play a minor role in rD'D3-FP half-life extension in mice, albumin fusion may potentially reduce other rD'D3-FP clearance mechanisms. We thus hypothesise several independent mechanisms that may contribute to rD'D3-FP half-life extension in higher order species.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CSL Innovation Pty Ltd, Parkville, Victoria, Australia. Electronic address: kim.lieu@csl.com.au.
- CSL Innovation GmbH, Marburg, Germany.
- CSL Innovation Pty Ltd, Parkville, Victoria, Australia.
Zitieren
APA
Lieu, K. G., Pestel, S., Maxwell, M., Liu, Y. H., Bass, G. T., Dai, Y., Glauser, I., Hofmann, M., Baz Morelli, A., Chia, J., & Verhagen, A. M. (2026). Albumin fusion of the rVWF fragment rD'D3 reduces internalisation by clearance receptor Stabilin-2. Blood Cells, Molecules, and Diseases, 119, 103000. https://doi.org/10.1016/j.bcmd.2026.103000
Vancouver
Lieu KG, Pestel S, Maxwell M, Liu YH, Bass GT, Dai Y, et al. Albumin fusion of the rVWF fragment rD'D3 reduces internalisation by clearance receptor Stabilin-2. Blood Cells, Molecules, and Diseases. 2026;119:103000. doi:10.1016/j.bcmd.2026.103000
BibTeX
@article{Lieu2026,
author = {Lieu, Kim G and Pestel, Sabine and Maxwell, Mhairi and Liu, Yu-Han and Bass, Greg T and Dai, Yun and Glauser, Isabelle and Hofmann, Marco and Baz Morelli, Adriana and Chia, Jenny and Verhagen, Anne M},
title = {Albumin fusion of the rVWF fragment rD'D3 reduces internalisation by clearance receptor Stabilin-2},
journal = {Blood Cells, Molecules, and Diseases},
year = {2026},
volume = {119},
pages = {103000},
doi = {10.1016/j.bcmd.2026.103000}
}
EUVIMED